St. Jude Medical Inc
featured
Earnings season kicks into high gear in the week ahead. Plus, at least 10 Fed speeches. How risk-averse are investors? Oh, this is going to put them to the test. Rest up.
» Read More
More
-
Check out which companies are making headlines before the bell Monday:
-
Stocks recovered from their lows Friday to close narrowly mixed, but the S&P 500 managed to pull off its seventh-straight week higher.
-
*Q4 profit of 90 cents excluding items tops analysts' 77 cents view. Feb 4- Edwards Lifesciences Corp on Monday posted fourth-quarter earnings that beat analyst expectations on strong sales of its replacement heart valve that is implanted in a less-invasive procedure than open-heart surgery.
-
Feb 1- St. Jude Medical Inc, frustrated by regulatory and product issues last year, vowed that it would meet or exceed its 2013 earnings forecast, even though it does not expect much of a recovery in the medical technology market. Chief Executive Dan Starks acknowledged that St.
-
*Expects 2013 EPS of $3.68- $3.73 vs est $3.62. Jan 23- St. Jude Medical Inc forecast 2013 earnings above market estimates after reporting a better-than-expected fourth-quarter profit as it cut costs, and the company's shares initially fell in early trading Wednesday, but had trimmed losses by midday.
-
*Expects 2013 EPS of $3.68- $3.73 vs est $3.62. Jan 23- St. Jude Medical Inc forecast 2013 earnings above market estimates after reporting a better-than-expected fourth-quarter profit as it cut costs, but the medical device maker's shares dipped amid skepticism that its markets would improve significantly.
-
A flood of earnings reports, including major technology and industrial companies, could make or break the stock market’s surprise January rally in the week ahead.
-
*FDA warning concerns quality system violations. Jan 14- St Jude Medical Inc said it received a warning letter from U.S. health officials concerning manufacturing issues at its Sylmar, California, plant, where it makes cardiac rhythm management devices.
-
*Excise tax seen collecting more than $30 bln over next decade. CHICAGO, Dec 20- The U.S. medical technology industry, once a haven for secure, high-paying jobs, is blaming a new tax meant to help fund the Affordable Care Act for upcoming layoffs.
-
*More competitors on horizon in Europe. Dec 4- Edwards Lifesciences Corp on Tuesday projected strong profit and sales growth in 2013, led by its Sapien artificial heart valve, which is implanted in a less-invasive procedure than traditional open-heart surgery.
-
Check out which companies are making headlines after the bell Thursday:
-
Oct 24- St. Jude Medical Inc said it received a Form 483 n otice from the U.S. Food and Drug Administration about its Sylmar, California, manufacturing plant, where it makes cardiac rhythm management products. A Form 483 from the FDA is a notice that lists its concerns after conducting a quality inspection.
-
NEW YORK-- Stocks that moved substantially or traded heavily Wednesday on the New York Stock Exchange and Nasdaq Stock Market:. Quest Diagnostics Inc., down $3.62 at $59.75. Dean Foods Co., up $1.92 at $16.96.
-
NEW YORK-- Shares of St. Jude Medical Inc. declined Wednesday after the medical device maker cut its 2012 revenue estimate and said it may get a warning from federal regulators about a defibrillator plant in California.
-
Among the earnings stories for Wednesday, Oct. 17, from The Associated Press:. _ Medical device maker St. Jude Medical Inc. reported third-quarter earnings that beat expectations, though company shares slumped as the executives warned that the company could receive a regulatory warning over a California manufacturing plant.
-
ST. PAUL, Minn.-- Medical device maker St. Jude Medical Inc. reported third-quarter earnings Wednesday that beat expectations, though company shares slumped as the executives warned that the company could receive a regulatory warning over a California manufacturing plant.
